HIGHLIGHTS
- who: Simone C. Oostindie from the Genmab, Utrecht, Netherlands, Department of Immunology, Leiden University Medical Center, Leiden, Netherlands. , Department of Antibody Engineering, Genentech, San Francisco, CA, USA. , Sparring Bioconsult, Odijk, Netherlands. , Lava Therapeutics, Utrecht, Netherlands. have published the Article: Avidity in antibody effector functions and biotherapeutic drug design, in the Journal: (JOURNAL)
- what: The authors describe how affinity and avidity tuning of engineered antibody formats are enabling a new wave of differentiated antibody drugs with tailored properties and novel functions, promising improved treatment options for a wide variety of diseases. This study investigates the pathways . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.